Heidi sells WBC 96.57: MD Anderson Department Chair Richard E. Champlin, M.D. Joins Actinium's Iomabâ¢-B Scientific Advisory Board
BC8 has been developed by Fred Hutchinson Cancer Research Center to target CD45, a pan-leukocytic antigen widely expressed on white blood cells. This antigen makes BC8 potentially useful in targeting white blood cells in preparation for hematopoietic stem ... ...
61 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home